Literature DB >> 20386868

Gene expression profiling of the hedgehog signaling pathway in human meningiomas.

Ingrid Laurendeau1, Marcela Ferrer, Delia Garrido, Nicky D'Haene, Patricia Ciavarelli, Armando Basso, Michel Vidaud, Ivan Bieche, Isabelle Salmon, Irene Szijan.   

Abstract

The Hedgehog (Hh) signaling pathway has an important role during embryogenesis and in adult life, regulating proliferation, angiogenesis, matrix remodeling and stem-cell renewal. Deregulation of the Hh pathway is involved in tumor development, since mutations in several components of this pathway were found in patients with basal cell carcinoma, medulloblastoma and other tumors; however, the role of Hh in meningiomas has not been studied yet. Meningiomas represent 30% of primary cranial tumors, are mostly benign and prevail in the second half of life. Novel therapies for meningiomas such as targeted molecular agents could use Hh pathway components. To provide information concerning molecular alterations, by use of real-time RT-PCR, we studied expression at the mRNA level of 32 Hh pathway and target genes in 36 meningioma specimens of different grades. mRNA levels of 16 genes, involved mainly in Hh pathway activation and cell proliferation, increased in meningiomas in comparison with normal tissue, whereas those of 7 genes, mainly related to Hh pathway repression, decreased. The most significant changes occurred in signal transduction (SMO) and GLI-transcription factor genes, and the target FOXM1 mRNA attained the highest values; their over-expression was found in aggressive and in benign tumors. Some proliferation-related genes (SPP1, IGF2) were overexpressed in higher meningioma grades. A correlation in expression between genes with a similar function was also found. Our results show a marked activation of the Hh pathway in meningiomas, which may be important for their biological and clinical characterization and would be useful for gene therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20386868      PMCID: PMC2896461          DOI: 10.2119/molmed.2010.00005

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  34 in total

1.  Evidence for the direct involvement of {beta}TrCP in Gli3 protein processing.

Authors:  Baolin Wang; Yanyun Li
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-21       Impact factor: 11.205

Review 2.  Shifting paradigms in Hedgehog signaling.

Authors:  Yu Wang; Andrew P McMahon; Benjamin L Allen
Journal:  Curr Opin Cell Biol       Date:  2007-02-15       Impact factor: 8.382

3.  Mouse Rab23 regulates hedgehog signaling from smoothened to Gli proteins.

Authors:  Jonathan T Eggenschwiler; Oleg V Bulgakov; Jian Qin; Tiansen Li; Kathryn V Anderson
Journal:  Dev Biol       Date:  2005-12-20       Impact factor: 3.582

Review 4.  Hedgehog signaling pathway and gastric cancer.

Authors:  Yuriko Katoh; Masaru Katoh
Journal:  Cancer Biol Ther       Date:  2005-10-18       Impact factor: 4.742

5.  Activation of the hedgehog pathway in human hepatocellular carcinomas.

Authors:  Shuhong Huang; Jing He; Xiaoli Zhang; Yuehong Bian; Ling Yang; Guorui Xie; Kefei Zhang; Wendell Tang; Arwen A Stelter; Qian Wang; Hongwei Zhang; Jingwu Xie
Journal:  Carcinogenesis       Date:  2006-02-25       Impact factor: 4.944

6.  Gli3 acts as a repressor downstream of Ihh in regulating two distinct steps of chondrocyte differentiation.

Authors:  Lydia Koziel; Manuela Wuelling; Sabine Schneider; Andrea Vortkamp
Journal:  Development       Date:  2005-12       Impact factor: 6.868

7.  Assignment of the gene encoding human Krüppel-related zinc finger protein 4 (GLI4) to 8q24.3 by fluorescent in situ hybridization.

Authors:  K Kas; I Wlodarska; E Meyen; H Van den Berghe; W J Van de Ven
Journal:  Cytogenet Cell Genet       Date:  1996

8.  Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling.

Authors:  Pilar Sanchez; Ana Maria Hernández; Barbara Stecca; Andrea J Kahler; Amy M DeGueme; Andrea Barrett; Mercedes Beyna; Milton W Datta; Sumana Datta; Ariel Ruiz i Altaba
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

9.  FOXE1, a new transcriptional target of GLI2 is expressed in human epidermis and basal cell carcinoma.

Authors:  Thomas Eichberger; Gerhard Regl; Mohammed S Ikram; Graham W Neill; Michael P Philpott; Fritz Aberger; Anna-Maria Frischauf
Journal:  J Invest Dermatol       Date:  2004-05       Impact factor: 8.551

10.  Hedgehog signaling: from the Drosophila cuticle to anti-cancer drugs.

Authors:  James Briscoe; Pascal Thérond
Journal:  Dev Cell       Date:  2005-02       Impact factor: 12.270

View more
  32 in total

1.  Immunohistochemical evidence of the prognostic value of hedgehog pathway components in primary gallbladder carcinoma.

Authors:  Jinmao Li; Tao Wu; Jianguo Lu; Yizhan Cao; Nuan Song; Tao Yang; Rui Dong; Yuan Yang; Li Zang; Xilin Du; Shengzhi Wang
Journal:  Surg Today       Date:  2012-03-10       Impact factor: 2.549

2.  Identification of epithelial membrane protein 2 (EMP2) as a molecular marker and correlate for angiogenesis in meningioma.

Authors:  Kunal S Patel; Sameer Kejriwal; Michel M Sun; Samasuk Thammachantha; Courtney Duong; Ann Chan; Nina Cherian; Prasanth Romiyo; Lynn K Gordon; William Yong; Madhuri Wadehra; Isaac Yang
Journal:  J Neurooncol       Date:  2020-01-24       Impact factor: 4.130

Review 3.  Advances in meningioma genetics: novel therapeutic opportunities.

Authors:  Matthias Preusser; Priscilla K Brastianos; Christian Mawrin
Journal:  Nat Rev Neurol       Date:  2018-01-05       Impact factor: 42.937

4.  Hedgehog-producing cancer cells respond to and require autocrine Hedgehog activity.

Authors:  Samer Singh; Zhiqiang Wang; Dennis Liang Fei; Kendall E Black; John A Goetz; Robert Tokhunts; Camilla Giambelli; Jezabel Rodriguez-Blanco; Jun Long; Ethan Lee; Karoline J Briegel; Pablo A Bejarano; Ethan Dmitrovsky; Anthony J Capobianco; David J Robbins
Journal:  Cancer Res       Date:  2011-05-12       Impact factor: 12.701

5.  Genomic analysis of synchronous intracranial meningiomas with different histological grades.

Authors:  Tamrin Chowdhury; Yongjin Yoo; Youngbeom Seo; Yun-Sik Dho; Sojin Kim; Anna Choi; Murim Choi; Sung-Hye Park; Chul-Kee Park; Sang Hyung Lee; Ji Yeoun Lee
Journal:  J Neurooncol       Date:  2018-02-08       Impact factor: 4.130

6.  Association between FOXM1 and hedgehog signaling pathway in human cervical carcinoma by tissue microarray analysis.

Authors:  Hong Chen; Jingjing Wang; Hong Yang; Dan Chen; Panpan Li
Journal:  Oncol Lett       Date:  2016-08-02       Impact factor: 2.967

Review 7.  Meningiomas from a developmental perspective: exploring the crossroads between meningeal embryology and tumorigenesis.

Authors:  Julien Boetto; Matthieu Peyre; Michel Kalamarides
Journal:  Acta Neurochir (Wien)       Date:  2020-11-20       Impact factor: 2.216

Review 8.  Meningiomas and Proteomics: Focus on New Potential Biomarkers and Molecular Pathways.

Authors:  Rosaria Viola Abbritti; Francesca Polito; Maria Cucinotta; Claudio Lo Giudice; Maria Caffo; Chiara Tomasello; Antonino Germanò; Mohammed Aguennouz
Journal:  Cancer Genomics Proteomics       Date:  2016 09-10       Impact factor: 4.069

9.  Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma.

Authors:  Ximena Bonilla; Laurent Parmentier; Bryan King; Fedor Bezrukov; Gürkan Kaya; Vincent Zoete; Vladimir B Seplyarskiy; Hayley J Sharpe; Thomas McKee; Audrey Letourneau; Pascale G Ribaux; Konstantin Popadin; Nicole Basset-Seguin; Rouaa Ben Chaabene; Federico A Santoni; Maria A Andrianova; Michel Guipponi; Marco Garieri; Carole Verdan; Kerstin Grosdemange; Olga Sumara; Martin Eilers; Iannis Aifantis; Olivier Michielin; Frederic J de Sauvage; Stylianos E Antonarakis; Sergey I Nikolaev
Journal:  Nat Genet       Date:  2016-03-07       Impact factor: 38.330

Review 10.  Spinal cord tumours: advances in genetics and their implications for treatment.

Authors:  Patricia L Zadnik; Ziya L Gokaslan; Peter C Burger; Chetan Bettegowda
Journal:  Nat Rev Neurol       Date:  2013-03-26       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.